REGN

HOLD

Regeneron Pharmaceuticals, Inc.

Healthcare · Rank #71 · Analyzed Apr 20, 2026

$750.57

Current Price

$1151.91

Intrinsic Value

+124.8%

Upside/Downside

8.7/10

Score

3/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score3/5.0

Framework RatingHOLD

Price vs Intrinsic ValueUndervalued by 124.8%

Fair Value Range

Low$240.66

Base (IV)$1151.91

High$1687.56

Entry Points

Conservative$240.66

Moderate$696.29

Aggressive$1151.91

Quality & Moat Breakdown

Return on Equity14.9% → 0.5/1.0

Debt LevelD/E 10 → 1.0/1.0

Revenue QualityGrowth 6.6%, margin Δ-38.0% → 0.5/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins31.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.